INTELLIGENT BIO SOLUTIONS INC. — Director's Dealing 2022

Oct 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2022-10-10

Reporting Person: Boyages Steven Constantine (Director, Interim CEO and Chairperson)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-10	Common Stock, par value $0.01 per share	A	75000	—	Acquired	75000	Direct